HOME > ARCHIVE
ARCHIVE
- STATISTICS
May 8, 2006
- SEMINAR
May 8, 2006
- REGULATORY NEWS IN BRIEF
May 8, 2006
- RDKK Supports Nursery for Female Doctors with Children
May 8, 2006
- JT Licenses New Drug Candidate to GSK
May 8, 2006
- SELF-MEDICATION NEWS IN BRIEF
May 8, 2006
- DIA WORKSHOP
May 8, 2006
- SURVEY 2 articles
May 8, 2006
- R&D NEWS IN BRIEF
May 8, 2006
- Sanofi-aventis Aims to
May 8, 2006
- Dr A. Endo Awarded Japan Prize for Discovery of Statins
May 8, 2006
- Hib Vaccine to Be Approved in 2006: Sanofi Pasteur
May 8, 2006
- SEMINAR
May 8, 2006
- Bayer Takeover of Schering
May 8, 2006
- OPINION
May 8, 2006
- GCP Auditing Business
May 8, 2006
- HUMAN RESOURCES NEWS IN BRIEF
May 8, 2006
- Epidemiological Data Essential for Strategic Marketing: Mr Robinson of Mattson Jack
May 8, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
May 8, 2006
- BUSINESS NEWS IN BRIEF
May 8, 2006
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
